Cost-effectiveness of camrelizumab added to chemotherapy in patients with advanced or metastatic esophageal squamous cell carcinoma
LI Li-zong
ZHAO Lei
ZHONG Xue
HUANG Jing
HUANG Lin
FENG Yu-fei
Machine-generated Keywords：
Publication Date：2022-12-31
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：6( 2498-2503 )